HLUBF:OTCMKTS
H Lundbeck A/S Class A
$6.85
0.00%
(0.00) 1D
Oct 8, 1:38:30 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Mkt. cap
54.89B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Mkt. cap
54.89B
Avg. vol.
108.00
Volume
1.00
52-wk high
$6.85
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
BigGo Finance
·
39 minutes ago
Global AI and Semiconductor Stocks Plunge; S&P 500 Tumbles 4.4% in a Single Day as Markets Watch Whether Three Central Banks Will Raise Rates in December
Yahoo Finance
·
11 hours ago
This Dividend King Yielding 2X the S&P 500 Looks Like a Buy in November.
BBN Times
·
15 hours ago
S&P 500 Futures End the Week Near 7,402 as Traders Brace for CPI
TradingView
·
23 hours ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com